Mar 07, 2023 / 01:30PM GMT
Operator
Good morning, and welcome to Voyager Therapeutics 2022 Fourth Quarter and Year-End Conference Call. (Operator Instructions) Please be advised this call is being recorded at the company's request. (Operator Instructions)
I would now like turn the call over to Pete Pfreundschuh, Chief Financial Officer.
Peter P. Pfreundschuh - Voyager Therapeutics, Inc. - CFO
Thank you, and Good morning. Joining me on today's call are Dr. Al Sandrock, our CEO; Dr. Todd Carter, our Chief Scientific Officer; and Allen Nunnally, our Chief Business Officer.
We issued our Q4 and Year-End 2022 press release this morning. The press release and 10-K are available on our website. We plan to provide a brief summary of key highlights from the quarter and reserve the majority of time for your Q&A.
In a moment, I will turn the call over to Al. Before I do this, I want to remind everyone that during this call, Voyager representatives may make forward-looking statements regarding future expectations, plans and prospects. All forward-looking statements are
Q4 2022 Voyager Therapeutics Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot